Estee Lauder subsidiary and OXIS resolve mitochondria patent dispute

Sep 7 2010

OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) and THE ESTEE LAUDER COMPANIES INC. (NYSE: EL) announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics ("AGI"), and Oxis over technology related to U.S. Patent No. 6,103,746 (the "746 Patent") and U.S. Patent No. 6,479,533 (the "533 Patent"), entitled "Methods and Compositions for the Protection of Mitochondria."  

An agreement between the parties provides Oxis with full title to the '746 and '533 Patents in exchange for Estee Lauder receiving a non-exclusive license under the '746 and '533 Patents within the cosmetic market.  The material terms and conditions are to remain confidential pursuant to the agreement.

SOURCE OXIS International, Inc.

Posted in: Medical Science News | Medical Patent News

Tags: , , , , , , ,

Comments (0)

Suggested Reading

New discovery reveals how exercise boosts muscle energy production
Study explains how the body’s internal clock influences inflammatory process of the immune system
Researchers aim to uncover causes of acquired hearing loss and find potential therapies
Study reveals how cancer cells evade chemotherapy in low-glucose environments
New therapies and technologies provide hope for age-related fertility challenges
Mitochondria’s division of labor sheds light on how cancer cells survive harsh conditions
Study unveils NAD's link to aging and disease development
CKMT2 regulates mitochondrial function and energy metabolism in type 2 diabetes

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Understanding metformin's mechanism in reducing blood sugar